SMS PHARMACEUTICALS LTD. - 532815 - Submission Of Information Regarding Issue Of Duplicate Share Certificates Under Regulation 39(3) Of The SEBI (LODR) Regulations, 2015
Submission of information regarding issue of duplicate share certificates under Regulation 39(3) of the SEBI (LODR) Regulations, 2015 SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
We are enclosing here with press release dated 20th January, 2022 regarding the Company receives non-exclusive license to manufacture and supply of molnupiravir (an oral COVID-19 medicine) through the Medicine Patent Pool (MPP). SMS PHARMACEUTICALS LTD. - 532815 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
In compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 we are forwarding herewith a copy of the Certificate dated 6th January, 2022, received from Aarthi Consultants Private Limited, Hyderabad, the Registrar and Share Transfer Agent of the Company for the quarter ended 31st December, 2021. SMS PHARMACEUTICALS LTD. - 532815 - Statement Of Investor Complaints For The Quarter Ended December 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- V S VenkatishDesignation :- Company Secretary and Compliance Officer SMS PHARMACEUTICALS LTD. - 532815 - Shareholding for the Period Ended December 31, 2021
SMS Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click here SMS PHARMACEUTICALS LTD. - 532815 - Closure of Trading Window
This is to inform you that the Trading Window for dealing in securities of the Company by Directors, Promoters, Designated Employees and Specified Connected Persons of the Company and associated of the Company shall remain closed with effect from 1st January, 2022 till 48 hours after the declaration of unaudited financial results for the 3rd quarter ended as on 31st December, 2021, in terms of the Code of Conduct of the Company. SMS PHARMACEUTICALS LTD. - 532815 - Submission Of Half Yearly Disclosure On Related Party Transactions. Ref: Regulation 23(9) Of The SEBI (Listing Obligations And Disclosures Requirements), Regulations, 2015
In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose disclosure of Related Party Transactions on a consolidated basis, in the format specified in the accounting standards for the half year ended 30th September, 2021. SMS PHARMACEUTICALS LTD. - 532815 - Submission Of Half Yearly Disclosure On Related Party Transactions. Ref: Regulation 23(9) Of The SEBI (Listing Obligations And Disclosures Requirements), Regulations, 2015
In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose disclosure of Related Party Transactions on a consolidated basis, in the format specified in the accounting standards for the half year ended 30th September, 2021. SMS PHARMACEUTICALS LTD. - 532815 - Intimation Of Schedule Of Analyst / Institutional Investor Meetings Under The SEBI (Listing Obligations And Disclosure Requirements), Regulations 2015.
Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be meeting Investors/Analysts (Participants) as per the details below. SMS PHARMACEUTICALS LTD. - 532815 - Earnings Call Transcript - Q2 FY22
Please find the enclosed transcript of the Earnings call for Q2FY22 of the Company held on Wednesday 17th, November, 2021. This will also be available on the Company's website https://smspharma.com/investor-relations/corporate-announcements/.